The association of in-hospital delirium with functional disability and cognitive impairment.
Europe’s TCR immunotherapy licensing deals surge in 2024
Licensing agreement deal values for innovator T-cell receptor (TCR) immunotherapy drugs for European biopharmaceutical companies increased by 325% (by $921 million) between 2023 to 2024